The Journal of Precision Medicine highlights Taconic's Dr. Michael Seiler who outlines how gene editing has progressed in recent years:
"If Helen of Troy possessed the face that launched a thousand ships, it is not a stretch to say that the publication in the summer of 2012 of "A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity" in the journal Science by Jennifer Doudna and Emmanuelle Charpentier, is the research that launched a thousand gene editing labs. The now well-known research detailed the use of clustered regularly interspaced short palindromic repeats (CRISPR) with CRISPR associated (Cas) protein for highly targeted gene editing."
![CRISPR-Cas9: The bold, new, fast, inexpensive frontier of gene editing](/content/dam/taconic/legacy/about-us/news/images/crispr-cas9-news.jpg)
Read the complete article at: TheJournalofPrecisionMedicine.com